Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 22,188 | 2,810 | N/A | N/A |
| Receivables | 1,455 | N/A | N/A | N/A |
| TOTAL | $24,401 | $3,054 | $N/A | $N/A |
| Non-Current Assets | ||||
| PPE Net | 579 | 750 | N/A | N/A |
| Other Non-Current Assets | 85 | 110 | 0 | 0 |
| TOTAL | $664 | $860 | $N/A | $N/A |
| Total Assets | $25,065 | $3,914 | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | N/A | 818 | N/A | N/A |
| Accounts payable and accrued liabilities | 415 | 197 | 0 | 0 |
| Accrued Expenses | 1,052 | 743 | N/A | N/A |
| Other current liabilities | 129 | 114 | N/A | N/A |
| TOTAL | $11,681 | $3,162 | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 4,793 | N/A | N/A | N/A |
| Deferred Revenues | 10,085 | 1,290 | N/A | N/A |
| Other Non-Current Liabilities | 569 | 386 | 0 | 0 |
| TOTAL | $7,391 | $607 | $N/A | $N/A |
| Total Liabilities | $19,072 | $3,769 | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 2 | 17 | N/A | N/A |
| Retained earnings | -45,259 | -48,791 | N/A | N/A |
| Other shareholders' equity | 36,828 | 34,672 | 0 | 0 |
| TOTAL | $5,993 | $145 | $N/A | $N/A |
| Total Liabilities And Equity | $25,065 | $3,914 | $0 | $0 |